2,465
Views
24
CrossRef citations to date
0
Altmetric
Articles

Exploring bioactive fraction of Sargassum wightii: In vitro elucidation of angiotensin-I-converting enzyme inhibition and antioxidant potential

, , &
Pages 674-684 | Received 28 Aug 2017, Accepted 15 Mar 2018, Published online: 04 May 2018

References

  • Lim, S.S.; Vos, T.; Flaxman, A.D.; Danaei, G.; Shibuya, K.; Adair-Rohani, H.; et al. A Comparative Risk Assessment of Burden of Disease and Injury Attributable to 67 Risk Factors and Risk Factor Clusters in 21 Regions, 1990-2010: A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380, 2224–2260. DOI: 10.1016/S0140-6736(12)61766-8.
  • Grossman, E.;. Does Increased Oxidative Stress Cause Hypertension? Diabetes Care 2008, 31, S185–S189. DOI: 10.2337/dc08-s246.
  • Nakazono, K.; Watanabe, N.; Matsuno, K.; Sasaki, J.; Sato, T.; Inoue, M. Does Superoxide Underlie the Pathogenesis of Hypertension? Proceedings of the National Academy of Sciences of the United States of America 1991, 88, 10045–10048. DOI: 10.1073/pnas.88.22.10045.
  • Paravicini, T. M.; Touyz, R. M. Redox Signaling in Hypertension. Cardiovascular research 2006, 71, 247–258. DOI: 10.1016/j.cardiores.2006.05.001.
  • Gonzalez, J.; Valls, N.; Brito, R.; Rodrigo, R. Essential Hypertension and Oxidative Stress: New Insights. World journal of cardiology 2014, 6, 353–366. DOI: 10.4330/wjc.v6.i6.353.
  • Rajagopalan, S.; Kurz, S.; Munzel, T.; Tarpey, M.; Freeman, B. A.; Griendling, K. K.; Harrison, D. G. Angiotensin II-mediated Hypertension in the Rat Increases Vascular Superoxide Production via Membrane NADH/NADPH Oxidase Activation. Contribution to Alterations of Vasomotor Tone. Journal of clinical investigation 1996, 97, 1916–1923. DOI: 10.1172/JCI118623.
  • Laursen, J. B.; Rajagopalan, S.; Galis, Z.; Tarpey, M.; Freeman, B. A.; Harrison, D. G. Role of Superoxide in Angiotensin II-induced but Not Catecholamine-Induced Hypertension. Circulation 1997, 95, 588–593. DOI: 10.1161/01.CIR.95.3.588.
  • Kumar, K. V.; Das, U. N. Are Free Radicals Involved in the Pathobiology of Human Essential Hypertension? Free radical research communications 1993, 19, 59–66. DOI: 10.3109/10715769309056499.
  • Parish, R. C.; Miller, L. J. Adverse Effects of Angiotensin Converting Enzyme (ACE) Inhibitors. An Update. Drug Safety 1992, 7, 14–31. DOI: 10.2165/00002018-199207010-00004.
  • Ardalan, M. R.; Rafieian-Kopaei, M. Antioxidant Supplementation in Hypertension. Journal of renal injury prevention 2014, 3, 39–40.
  • Tamadon, M. R.; Baradaran, A.; Rafieian-Kopaei, M. Antioxidant and Kidney Protection; Differential Impacts of Single and Whole Natural Antioxidants. Journal of renal injury prevention 2014, 3, 41–42.
  • Baradaran, A.; Nasri, H.; Rafieian-Kopaei, M. Oxidative Stress and Hypertension: Possibility of Hypertension Therapy with Antioxidants. Journal of research in medical sciences 2014, 19, 358–367.
  • Liu, L.; Heinrich, M.; Myers, S.; Dworjanyn, S. A. Towards A Better Understanding of Medicinal Uses of the Brown Seaweed Sargassum in Traditional Chinese Medicine: A Phytochemical and Pharmacological Review. Journal of ethnopharmacology 2012, 142, 591–619. DOI: 10.1016/j.jep.2012.05.046.
  • Syad, A. N.; Shunmugiah, K. P.; Kasi, P. D. Antioxidant and Anti-Cholinesterase Activity of Sargassum Wightii. Pharmaceutical biology 2013, 51, 1401–1410. DOI: 10.3109/13880209.2013.793721.
  • Sujatha, D.; Singh, K.; Vohra, M.; Kumar, K. V.; Sunitha, S. Antilithiatic Activity of Phlorotannin Rich Extract of Sarghassum Wightii on Calcium Oxalate Urolithiais - InVitro and in Vivo Evaluation. International brazilian journal of uUrology 2015, 41, 511–520. DOI: 10.1590/S1677-5538.IBJU.2014.0357.
  • Maneesh, A.; Chakraborty, K.; Makkar, F. Pharmacological Activities of Brown Seaweed Sargassum Wightii (Family Sargassaceae) Using Different in Vitro Models. International journal of food properties 2017, 20, 931–945. DOI: 10.1080/10942912.2016.1189434.
  • Blois, S.;. A Note on Free Radical Formation in Biologically Occurring Quinones. Biochimica et biophysica acta 1955, 18, 165. DOI: 10.1016/0006-3002(55)90038-X.
  • Benzie, I. F.; Strain, J. J. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of “Antioxidant Power”: The FRAP Assay. Analytical biochemistry 1996, 239, 70–76. DOI: 10.1006/abio.1996.0292.
  • Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant Activity Applying an Improved ABTS Radical Cation Decolorization Assay. Free radical biology and medicine 1999, 26, 1231–1237. DOI: 10.1016/S0891-5849(98)00315-3.
  • Cushman, D. W.; Cheung, H. S. Spectrophotometric Assay and Properties of the Angiotensin-Converting Enzyme of Rabbit Lung. Biochemical pharmacology 1971, 20, 1637–1648. DOI: 10.1016/0006-2952(71)90292-9.
  • Ko, S.-C.; Jung, W.-K.; Kang, S.-M.; Lee, S.-H.; Kang, M. C.; Heo, S.-J.; Kang, K.-H.; Kim, Y.-T.; Park, S.-J.; Jeong, Y. Angiotensin I-Converting Enzyme (ACE) Inhibition and Nitric Oxide (No)-Mediated Antihypertensive Effect of Octaphlorethol A Isolated from Ishige Sinicola: In Vitro Molecular Mechanism and in Vivo SHR Model. Journal of functional foods 2015, 18, 289–299. DOI: 10.1016/j.jff.2015.07.003.
  • Lineweaver, H.; Burk, D. The Determination of Enzyme Dissociation Constants. Journal of the american chemical society 1934, 56(3), 658–666. DOI: 10.1021/ja01318a036.
  • Dixon, M.;. The Determination of Enzyme Inhibitor Constants. Biochemical journal 1953, 55, 170–171. DOI: 10.1042/bj0550170.
  • Leyton, A.; Pezoa-Conte, R.; Barriga, A.; Buschmann, A.; Mäki-Arvela, P.; Mikkola, J.-P.; Lienqueo, M. Identification and Efficient Extraction Method of Phlorotannins from the Brown Seaweed Macrocystis Pyrifera Using an Orthogonal Experimental Design. Algal research 2016, 16, 201–208. DOI: 10.1016/j.algal.2016.03.019.
  • Lee, S. H.; Kang, S. M.; Ko, S. C.; Kang, M. C.; Jeon, Y. J.; Octaphlorethol, A. A Novel Phenolic Compound Isolated from Ishige Foliacea, Protects against Streptozotocin-Induced Pancreatic Beta Cell Damage by Reducing Oxidative Stress and Apoptosis. Food and chemical toxicology 2013, 59, 643–649. DOI: 10.1016/j.fct.2013.07.011.
  • Ferreres, F.; Lopes, G.; Gil-Izquierdo, A.; Andrade, P. B.; Sousa, C.; Mouga, T.; Valentão, P. Phlorotannin Extracts from Fucales Characterized by HPLC-DAD-ESI-MSn: Approaches to Hyaluronidase Inhibitory Capacity and Antioxidant Properties. Marine drugs 2012, 10, 2766–2781. DOI: 10.3390/md10122766.
  • Kang, S.-M.; Heo, S.-J.; Kim, K.-N.; Lee, S.-H.; Jeon, Y.-J. Isolation and Identification of New Compound, 2, 7 ″-Phloroglucinol-6, 6′-Bieckol from Brown Algae, Ecklonia Cava and Its Antioxidant Effect. Journal of functional foods 2012, 4, 158–166. DOI: 10.1016/j.jff.2011.10.001.
  • Jung, H. A.; Hyun, S. K.; Kim, H. R.; Choi, J. S. Angiotensin‐Converting Enzyme I Inhibitory Activity of Phlorotannins from Ecklonia Stolonifera. Fisheries science 2006, 72, 1292–1299. DOI: 10.1111/fis.2006.72.issue-6.
  • Athukorala, Y.; Jeon, Y.-J. Screening for Angiotensin 1-Converting Enzyme Inhibitory Activity of Ecklonia Cava. Preventive nutrition and food science 2005, 10, 134–139. DOI: 10.3746/jfn.2005.10.2.134.
  • Paiva, L.; Lima, E.; Neto, A. I.; Baptista, J. Angiotensin I-Converting Enzyme (ACE) Inhibitory Activity of Fucus Spiralis Macroalgae and Influence of the Extracts Storage temperature-A Short Report. Journal of pharmaceutical and biomedical analysis 2016, 131, 503–507. DOI: 10.1016/j.jpba.2016.08.029.
  • Wijesinghe, W.; Ko, S.-C.; Jeon, Y.-J. Effect of Phlorotannins Isolated from Ecklonia Cava on Angiotensin I-Converting Enzyme (ACE) Inhibitory Activity. Nutrition research and practice 2011, 5, 93–100. DOI: 10.4162/nrp.2011.5.2.93.
  • Ko, S.-C.; Kang, M. C.; Kang, N.; Kim, H.-S.; Lee, S.-H.; Ahn, G.; Jung, W.-K.; Jeon, Y.-J. Effect of Angiotensin I-Converting Enzyme (ACE) Inhibition and Nitric Oxide (NO) Production of 6, 6′-Bieckol, a Marine Algal Polyphenol and Its Anti-Hypertensive Effect in Spontaneously Hypertensive Rats. Process biochemistry 2017, 58, 326–332. DOI: 10.1016/j.procbio.2017.04.014.
  • Al Shukor, N.; Van Camp, J.; Gonzales, G. B.; Staljanssens, D.; Struijs, K.; Zotti, M. J.; Raes, K.; Smagghe, G. Angiotensin-Converting Enzyme Inhibitory Effects by Plant Phenolic Compounds: A Study of Structure Activity Relationships. Journal of agricultural and food chemistry 2013, 61, 11832–11839. DOI: 10.1021/jf404641v.
  • Wijesekara, I.; Kim, S.-K. Angiotensin-I-converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical Industry. Marine Drugs 2010, 8, 1080–1093. DOI: 10.3390/md8041080.
  • Liu, J.-C.; Hsu, F.-L.; Tsai, J.-C.; Chan, P.; Liu, J. Y.-H.; Thomas, G. N.; Tomlinson, B.; Lo, M.-Y.; Lin, J.-Y. Antihypertensive Effects of Tannins Isolated from Traditional Chinese Herbs as Non-Specific Inhibitors of Angiontensin Converting Enzyme. Life Sciences 2003, 73, 1543–1555. DOI: 10.1016/S0024-3205(03)00481-8.